SCHEMBL27084749

SCHEMBL27084749

CCN(CC)CCc1c[nH]c2cccc(OC(=O)CCCC(=O)O)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 10/20 0.58
▸ HTR1A P08908 5/20 0.56
▸ HTR2C P28335 2/20 0.47
▸ HTR2B P41595 2/20 0.47
▸ HTR6 P50406 3/20 0.47
▸ MTNR1A P48039 1/20 0.43
▸ MTNR1B P49286 1/20 0.43
▸ HTR1B P28222 2/20 0.41
▸ HTR1D P28221 2/20 0.41
▸ DRD1 P21728 1/20 0.41
▸ HTR1E P28566 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ HTR5A P47898 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29112599 0.98 HTR2A (0.60) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27084756 0.95 HTR2A (0.58) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27084973 0.94 HTR1A (0.58) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27085219 0.93 HTR2A (0.60) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27084681 0.93 HTR2A (0.59) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL29112596 0.91 HTR2A (0.54) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL29112606 0.91 HTR2A (0.62) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27084849 0.89 HTR2A (0.56) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL27085070 0.89 HTR1A (0.58) HTR2AHTR1AHTR2CHTR2BHTR6
SCHEMBL24168730 0.89 HTR2A (0.68) HTR2AHTR1AHTR2CHTR2BHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES COMPASS PATHFINDER LIMITED (GB) 2024-02-08 — — US disclosed
CN-117120415-A Modified indole alkaloids for therapeutic use 指南针探路者有限公司 2023-11-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES INMT, AANAT, HNMT HTR2A 53/4885HTR1A 181/4885HTR2C 482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback